TEVA-CAPTOPRIL
As listed in the register: TEVA-CAPTOPRIL
50 mg · tablet
- Prescription only
- Heart, blood pressure and circulation
- Active substance
- Captopril
- Made by
- Teva Canada Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (captopril). It describes the substance, not this exact product.
The mechanism of action of captopril tablets have not yet been fully elucidated.
Its beneficial effects in hypertension and heart failure appear to result primarily from suppression of the renin-angiotensin-aldosterone system.
In a 24-hour period, over 95 percent of the absorbed dose is eliminated in the urine; 40 to 50 percent is unchanged drug; most of the remainder is the disulfide dimer of captopril and captopril-cysteine disulfide.
The presence of food in the gastrointestinal tract reduces absorption by about 30 to 40 percent; captopril therefore should be given one hour before meals.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-09-14
Safety of the active substance
From the US prescribing label for the same active substance (captopril). It describes the substance, not this exact product.
WARNING: FETAL TOXICITY When pregnancy is detected, discontinue captopril tablets as soon as possible.
- Captopril tablets are contraindicated in patients who are hypersensitive to this product or any other angiotensin- converting enzyme inhibitor (e.g., a patient who has experienced angioedema during therapy with any other ACE inhibitor).
- Do not co-administer aliskiren with captopril tablets in patients with diabetes (see PRECAUTIONS: Drug Interactions ).
- Do not administer captopril tablets within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor (see PRECAUTIONS: Drug Interactions ).
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Spain9 matching products
- CAPTOPRIL ALTER 50 mg · comprimido
- CAPTOPRIL ARISTO 50 mg · comprimido
- CAPTOPRIL CINFA 50 mg captopril · comprimido
- CAPTOPRIL MABO 50 mg · comprimido
- CAPTOPRIL MYLAN 50 mg captopril · comprimido
- CAPTOPRIL NORMON Captopril 50 mg · comprimido
- CAPTOPRIL QUALIGEN 50 mg · comprimido
- CAPTOPRIL STADA 50 mg · comprimido
France4 matching products
Netherlands2 matching products
Details
| Made by | Teva Canada Limited |
|---|---|
| Active substance | Captopril |
| Used in | Heart, blood pressure and circulation |
| Strength | 50 mg |
| Form | tablet |
| Classification | C09AA01 · Heart, blood pressure and circulation |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 01942980 |
| DPD drug code | 11764 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.